These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16492422)

  • 21. On the therapeutic action of SSRI medications.
    Levine FJ
    J Am Psychoanal Assoc; 2004; 52(2):492-3; author reply 493-8. PubMed ID: 15222457
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective serotonin re-uptake inhibitors for children and adolescents.
    Ziervogel CF
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I20-6. PubMed ID: 11140777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The serotonin transporter in psychiatric disorders: insights from PET imaging.
    Spies M; Knudsen GM; Lanzenberger R; Kasper S
    Lancet Psychiatry; 2015 Aug; 2(8):743-755. PubMed ID: 26249305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxetine and its uses in psychiatry.
    Bell C; Nutt D
    Hosp Med; 1999 May; 60(5):353-6. PubMed ID: 10396411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors.
    Vythilingum B; Cartwright C; Hollander E
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S7-13. PubMed ID: 11110014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Child psychopharmacology comes of age.
    Rapoport JL
    JAMA; 1998 Nov; 280(20):1785. PubMed ID: 9842957
    [No Abstract]   [Full Text] [Related]  

  • 28. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Zohar J; Westenberg HG
    Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure.
    Arnold DH
    Pediatr Rev; 2002 Dec; 23(12):427-32. PubMed ID: 12456895
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of psychotropic drugs in children].
    Purper-Ouakil D
    Arch Pediatr; 2008 Dec; 15(12):1834-6. PubMed ID: 18995997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series.
    Dell'Osso B; Mundo E; Altamura AC
    CNS Spectr; 2006 Nov; 11(11):879-83; quiz 885. PubMed ID: 17075559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Drug Ther Bull; 1995 Jun; 33(6):47-8. PubMed ID: 7587998
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment response and redefining diagnostic boundaries.
    Hollander E
    CNS Spectr; 2008 Dec; 13(12):1020-1. PubMed ID: 19179937
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A; Hollander E
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the therapeutic action of SSRI medications.
    Sandberg LS
    J Am Psychoanal Assoc; 2004; 52(2):490-1; author reply 493-8. PubMed ID: 15222456
    [No Abstract]   [Full Text] [Related]  

  • 37. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the therapeutic action of SSRI medications.
    Levinson MH
    J Am Psychoanal Assoc; 2004; 52(2):483-6; author reply 493-8. PubMed ID: 15222453
    [No Abstract]   [Full Text] [Related]  

  • 39. Improving the quality of care for depressed patients with comorbid psychiatric disorders: a review.
    Dunner DL
    Clin Perform Qual Health Care; 1997; 5(1):11-5. PubMed ID: 10164994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.
    DeVane CL; Sallee FR
    J Clin Psychiatry; 1996 Feb; 57(2):55-66. PubMed ID: 8591970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.